Ophthalmology in California

Suzhou Belle Healthcare Technology Co., Ltd. is a China-based manufacturer of precision micro-surgical instruments specialized in ophthalmology and ENT (otorhinolaryngology) applications. The company operates a 4,500 m² facility with 1,000 m² of GMP-certified cleanroom capacity for Class II and Class III medical device production. Belle manufactures both reusable and disposable surgical instruments with advanced precision capabilities, including 5-axis CNC machining, laser processing, and 3D microscope measurement equipment. Product lines include ophthalmic knives, cataract instrument sets, glaucoma surgical sets, vitreo-retinal instrument sets, refractive surgery instruments, keratoplasty sets, strabismus correction instruments, and ophthalmic plastic surgery instrument sets. The company has 8+ years of OEM/ODM experience serving hospitals and medical institutions in the US, Germany, and Switzerland. Belle offers comprehensive services including custom design and manufacturing, OEM production under APQP management systems, and maintenance services for reusable instruments. The company emphasizes craftsmanship, precision mechanical and surface treatment capabilities, and on-time customized delivery. Quality management and regulatory compliance are core operational elements, though specific FDA or ISO certifications are referenced on the site but not detailed in the fetched content.

Illuco Co, LTD is a Korea-based manufacturer of premium optical diagnostic and visualization equipment for medical and dental professionals. The company specializes in loupes (magnification eyepieces), headlights, dermatoscopes, and dental mirrors—products designed for dental practices, surgical environments, dermatology clinics, and veterinary ophthalmology. All products are designed and assembled in Korea and backed by patents and industry awards. Illuco loupes are available in multiple configurations including Through-the-Lens (TTL) Galilean and prismatic designs, angled models (Ergo X line), and flip-up styles with magnification ranges from 2x to 10x. Headlight offerings include both wired and wireless rechargeable models with adjustable brightness levels and universal adapter compatibility. The IDS-9100 dermatoscope provides 12x optical magnification for skin lesion assessment. Dental mirrors feature anti-fog, water-repellent coatings and stainless-steel construction. The company serves dental hygienists, surgeons, dermatologists, veterinary specialists, and students/residents. Products are sold through direct e-commerce and wholesale partnership channels. The company maintains a Brea, CA office for US operations and customer fittings. All products undergo rigorous quality control with emphasis on optical clarity, ergonomic comfort, and clinical reliability. No specific FDA 510(k) or ISO certifications are mentioned on the website.

TEKIA, INC manufactures intraocular lenses (IOLs) for cataract surgery and refractive lens exchange procedures. The company produces spherical biconvex design IOLs under the Tek-Lens product line, including hydrophobic acrylic formulations. Product portfolio includes Model 872S and Model 900 (hydrophobic acrylic IOL) variants. IOLs are precision optical medical devices implanted during cataract removal or presbyopia correction surgeries. The company serves ophthalmologists and cataract surgery centers. No specific regulatory certifications or manufacturing details were visible on the fetched content.

Alira Medical Devices is a US-based manufacturer and supplier of high-quality surgical instruments and medical devices headquartered in Sherman Oaks, California. The company serves medical practitioners across multiple specialties including plastic surgery, liposuction, gynecology, breast surgery, dental surgery, rhinoplasty, and ophthalmology. Alira offers an extensive catalog of surgical instruments—including forceps, retractors, scissors, bone instruments, electrosurgical instruments, and specialty tools—alongside advanced surgical equipment such as endoscopic systems, anesthesia workstations, ultrasound systems, and patient monitoring solutions. The company is also an authorized distributor of premium brands including Mindray, Nouvag AG, Tuttnauer, Aesthetics Biomedical, and Woodpecker. Beyond product supply, Alira provides comprehensive instrument repair services for both proprietary and third-party equipment, emphasizing quality, precision, and customer service as core differentiators.

Accurate Surgical & Scientific Instruments Corp. (ASSI) is a leading manufacturer of precision surgical instruments for specialized surgical disciplines. With nearly four decades of industry experience, ASSI supplies a comprehensive range of expertly crafted instruments including bipolar and monopolar forceps, scissors, needle holders, retractors, microvascular clamps, and specialty tools for microsurgery, hand surgery, neurosurgery, plastic and reconstructive surgery, ophthalmology, ENT, urology, and vascular surgery. The company emphasizes precision engineering, quality materials (stainless steel, titanium, insulated variants), and customer service. Products span electrosurgical instruments, bone and soft tissue surgery tools, and specialized microsurgical equipment. ASSI operates manufacturing and distribution facilities on both US coasts with B2B direct sales to hospitals, surgical centers, and medical professionals.

Medennium designs, develops, manufactures, and markets implantable ophthalmic devices for the treatment of myopia, aphakia, hyperopia, and dry eye. The company has over 20 years of innovation in vision correction solutions. Product portfolio includes phakic intraocular lenses (MPL™ system) for permanent correction of severe myopia and hyperopia, conventional intraocular lenses (IOLs) manufactured from proprietary Aurium™ material with blue and violet light filtering capabilities, and SmartPLUG™ punctal plugs for dry eye management. The Aurium™ material supports small incision (sub-2.5 mm) injector compatibility in single-piece and three-piece lens configurations. SmartPLUG™ is a removable, shape-conforming tear duct plug registered in the United States, Europe, Latin America, and multiple Asian regions. The company distributes globally through international partnerships and maintains manufacturing and regulatory compliance across major markets. Products address both surgical cataract and refractive correction needs for ophthalmology practices and surgical centers.

Tecfen Medical manufactures and distributes ophthalmic surgical disposables and post-operative care products to over 60 countries worldwide. The company specializes in precision ophthalmic surgical consumables including ophthalmic surgical drapes, CONTROLCUT™ ophthalmic knives and blades, and PVA and cellulose eye sponges. Tecfen Medical also offers comprehensive post-operative care kits designed for post-cataract and post-LASIK procedures. The company has been in operation for approximately 40 years and maintains ISO 13485:2016 certification for medical device quality management systems. Tecfen Medical distributes through established partnerships, including an exclusive European distributor arrangement with Simovision® in Belgium for post-operative products. The company actively participates in major ophthalmology conferences including the American Academy of Ophthalmology (AAO) and the European Society of Cataract and Refractive Surgeons (ESCRS) Congress. The company serves eye care professionals including ophthalmologists, surgical centers, and ophthalmic clinics globally, with a strong reputation for product quality, competitive pricing, and responsive customer service. Manufacturing and distribution capabilities are based in Santa Barbara, California.

ViaLase Inc. is a clinical-stage medical technology company developing innovative femtosecond laser solutions for glaucoma treatment. The company's proprietary ViaLuxe™ Laser System performs FLIGHT (Femtosecond Laser Image Guided High-Precision Trabeculotomy), a noninvasive procedure that creates apertures through the trabecular meshwork to manage mild to moderate primary open-angle glaucoma. Unlike traditional glaucoma interventions—which suffer from high noncompliance (topical medications), limited efficacy (selective laser trabeculoplasty), invasiveness (MIGS, filtration surgery)—ViaLase's approach combines non-incisional delivery with proprietary HD imaging for enhanced visualization and treatment validation. The technology eliminates vision-threatening complications associated with traditional surgery while allowing standalone execution. Led by CEO Shawn O'Neil and founder/CTO Tibor Juhasz, PhD, ViaLase has raised $40 million and is advancing regulatory clearance in the U.S. and European markets with significant commercial and clinical milestones ahead.

TSK Laboratory International is a Japan-based manufacturer specializing in custom needle solutions and medical devices for pharmaceutical and medical device companies worldwide. The company develops and manufactures specialty needles with proprietary designs and materials, supported by multiple patents. Primary markets served include aesthetic medicine, interventional radiology, ophthalmology, and dental applications. Core product lines include low dead space needles (minimizing product loss in syringes), STERiGLIDE cannula systems (optimized for reduced tissue trauma and bruising), and custom needle projects tailored to pharmaceutical partners' specifications. The company emphasizes innovation in needle design and materials to improve clinical outcomes, patient safety, and injection comfort. TSK Laboratory maintains CE mark certification and serves as a preferred partner for leading global pharmaceutical and medical device manufacturers. While the site references custom solutions for pharma companies, the primary business model centers on needle and cannula manufacturing rather than finished pharmaceutical products.

Viz.ai is an AI-powered care coordination platform that leverages over 50 FDA-cleared algorithms to analyze medical imaging data and detect suspected diseases in real time. The company's flagship product, Viz.ai One®, autodetects conditions across multiple therapeutic areas including neurovascular disease, vascular conditions, cardiac imaging, trauma, and general radiology. The platform integrates specialized suites—Viz Neuro, Viz Cardio, Viz Vascular, Viz Trauma, and Viz Radiology—designed to accelerate diagnosis, streamline clinical workflows, and facilitate faster treatment decisions in acute care settings. Deployed in over 1,700 hospitals and health systems across the U.S. and Europe, Viz.ai's technology processes CT scans, EKGs, echocardiograms, and other imaging modalities to deliver automated assessments and real-time alerts to clinicians via mobile and desktop devices. The platform also supports life sciences partnerships with pharmaceutical and medical device companies for clinical trial optimization and disease-specific research applications.

Altaviz, LLC is a medical device innovation and design firm specializing in advanced drug delivery systems and ophthalmic solutions. Founded in 2012 and based in Irvine, California, the company develops proprietary platform technologies for the medical device, pharmaceutical, and biotechnology sectors. Altaviz offers modular framework solutions including autoinjectors, fluid injectors, gas injectors, and implant delivery systems—all designed for rapid customization to address specific client engineering challenges. The company provides comprehensive services spanning concept development, product engineering, technology transfer, and post-market support. A key innovation focus is medical-grade compressed gas technology for precision drug delivery and therapy applications. Altaviz serves startups through established firms, combining scalable manufacturing expertise with high-performance design to enhance patient safety and clinical outcomes.

KeraMed, Inc. is an ISO 13485:2016 and CE Mark certified medical device manufacturer specializing in minimally invasive corneal surgery solutions. The company develops innovative foldable artificial cornea implants designed for synthetic lamellar keratoplasty through small surgical incisions. KeraMed's flagship product, the KeraKlear Artificial Cornea, treats corneal blindness conditions including keratoconus, corneal scars, corneal dystrophies, limbal stem cell deficiency, corneal edema, and failed corneal transplants. The device can be implanted at depths ranging from 300 to 700 microns to replace opacified or edematous corneal tissue. By enabling smaller incisions than traditional methods, KeraMed's devices support faster surgery, accelerated patient recovery, and preservation of corneal structural integrity. The company has received SBA Tibbetts Award recognition and conducts clinical evaluations of its investigational devices internationally.

Boston Scientific Corporation is a global medical device manufacturer serving multiple clinical specialties including cardiology, urology, gastroenterology, interventional radiology, electrophysiology, neurology, pain management, vascular surgery, and structural heart disease. The company manufactures and distributes a broad portfolio of minimally invasive medical devices, including cardiac rhythm management systems, interventional cardiology devices, electrophysiology catheters and mapping systems, spinal cord stimulation systems for pain management, urological devices, endoscopy and visualization systems, defibrillators, and interventional oncology equipment. Boston Scientific operates a healthcare professional portal providing online training through EDUCARE, e-commerce ordering, reimbursement resources, and comprehensive customer support with specialty-specific representative contact networks. The organization serves hospitals, ambulatory surgery centers, and healthcare professionals across the United States through direct sales and support teams organized by medical specialty. Products undergo rigorous regulatory compliance (FDA 510(k), international certifications) and the company emphasizes quality assurance and product safety as core organizational values. Customer care is available via a dedicated U.S. customer service line, with extended business hours Monday–Friday.

K.C. Pharmaceuticals is a Pomona, California–based private-label ophthalmic pharmaceutical and medical device manufacturer specializing in eye care and lens care products. The company is the largest private-label eye care supplier for eye care and lens care products in North America, servicing 26 of the 30 largest US retailers across food, drug, and mass-market channels. KC distributes to over 200 distribution centers serving 90,000+ stores nationwide. The company operates approximately 150,000 square feet across five buildings at its Pomona campus, including two manufacturing facilities, three warehouses, and a corporate office. KC maintains FDA-inspected manufacturing capabilities with over 35 years of experience in aseptic fill manufacturing and state-of-the-art equipment. The company has an experienced R&D team focused on first-to-market innovations in ophthalmic products. Product portfolio includes redness relief eye drops, dry eye relief eye drops, preservative-free eye drops, eye ointment and eye wash formulations, and contact lens care solutions. All products are developed and manufactured under private-label agreements for major US retailers. KC operates under an FDA-regulated facility and maintains quality and regulatory compliance standards appropriate for pharmaceutical and medical device manufacturing.

RxSight Inc. is a medical device company specializing in advanced intraocular lens technology for cataract surgery. The company manufactures and markets the Light Adjustable Lens (LAL), a proprietary intraocular lens that can be customized and refined after cataract surgery using non-invasive light-based adjustments. This represents a significant advancement in refractive cataract surgery, allowing surgeons and patients to achieve optimal visual outcomes post-operatively by adjusting the lens power without additional surgical intervention. The LAL technology addresses common post-operative refractive errors and enables personalized vision correction. RxSight serves ophthalmologists, surgical centers, and hospitals performing cataract procedures, as well as cataract patients seeking premium vision correction options. The company maintains a patient-facing and healthcare professional-focused marketing approach, indicating comprehensive engagement across the surgical ecosystem.

HOYA Surgical Optics is a global leader in intraocular lens (IOL) design, manufacturing, and distribution for cataract surgery and vision correction. The company specializes in preloaded IOL systems and personalized ophthalmic solutions, serving ophthalmologists and surgical centers worldwide. Primary product lines include Vivinex™ (premium IOL platform), Nanex™ (advanced compact IOL), and iSert® (preloaded delivery system), available in monofocal, multifocal, and toric configurations. HOYA Surgical Optics provides comprehensive clinical support through the Masters Video Library (ophthalmic education platform), CLEARlog (clinical outcomes tracking), and the HOYA Toric Calculator for surgical planning. The company maintains regulatory compliance with FDA 510(k) clearances and international standards (CE, ISO 13485) for IOL manufacturing and preloaded systems. Services include technical support, surgeon training, clinical education resources, and distributor relationships across North America, Europe, Asia-Pacific, and emerging markets. HOYA Surgical Optics operates as a division of HOYA Medical Singapore Pte. Ltd., leveraging the parent company's expertise in precision optics and medical device manufacturing.

New World Medical, Inc. is a specialized surgical device manufacturer focused on glaucoma treatment solutions. Founded over 35 years ago, the company develops and distributes innovative implantable and minimally invasive devices for intraocular pressure management and vision preservation. The product portfolio includes the Ahmed® Glaucoma Valve, a proprietary valved drainage device; STREAMLINE® Surgical System, an implant-free solution utilizing ClickPulse® technology; Ahmed ClearPath®, a non-valved drainage option; KDB GLIDE®, a goniotomy surgical instrument; VIA360™ Surgical System for viscoelastic delivery; and human allograft tissue for glaucoma procedures. Products are marketed to ophthalmologists and ophthalmic surgical centers globally. The company operates in over 78 countries and emphasizes patient access over profit maximization, particularly in underserved markets. New World Medical maintains strong research and development capabilities and partnerships with surgeons and distributors worldwide. The organization dedicates 10% of annual profits to the Sidra Tree Foundation to democratize global eye care access. While specific FDA or regulatory certifications are not detailed in the provided content, the company's 35-year track record and international distribution suggest established regulatory compliance.

NeurOptics is a worldwide leader in pupillometry technology for critical care, neurology, neurosurgery, emergency medicine, and applied research. The company develops and markets the NPi-300 Pupillometer, a handheld device that provides objective, quantitative assessment of pupil size and reactivity independent of examiner variability. The NPi-300 is adopted in over 1,000 U.S. hospitals and represented in more than 50 countries globally. The device measures pupillary responses and constriction velocity, enabling clinicians to detect subtle changes in pupillary response that may indicate increased intracranial pressure, neurological decline, or brain injury—particularly valuable in sedated or comatose patients where subjective penlight examination is unreliable. NeurOptics also provides pupillometry instrumentation for applied research applications, supporting both human and animal research across various clinical and research settings. The company emphasizes device integration with electronic medical records (EMR) to streamline clinical workflows and enable trend analysis of pupillary data as a vital sign. The NPi-300 is used extensively in neurocritical care units, stroke services, trauma centers, and cardiac arrest care settings. Clinical evidence supports the device in management of traumatic brain injury, cardiac arrest, malignant cerebral edema, and assessment for brain death determination.

Medical Instrument Development Laboratories, Inc. (MID Labs) is a California-based manufacturer of ophthalmic surgical devices founded in 1981. Specializing in vitreoretinal surgery instruments, the company pioneers vitrectomy technology designed to prevent blindness from retinal diseases and traumatic eye injuries. MID Labs manufactures precision instruments including vitreous cutters, bi-blade vitreous cutters, and single-step cannula insertion systems. The company operates a vertically integrated manufacturing facility in San Leandro and distributes products to over 30 countries worldwide. MID Labs holds multiple patents in ophthalmic surgical technology and maintains FDA certification. In addition to branded product offerings, the company provides contract manufacturing services to corporate clients, leveraging expertise in precision surgical instrument design and advanced aspiration systems. The organization emphasizes research, innovation, engineering excellence, and quality assurance across all product lines.

Steven R. Young, Ocularist, Inc. is a specialized provider of ocular prosthetic services and maxillo-facial prosthetics, operating since 1975. The company manufactures custom ocular prosthetics (artificial eyes), scleral cover shells, and custom maxillo-facial prosthetics. The practice also specializes in orbital growth management for infants and small children with micro-ophthalmos. Led by Steven R. Young, B.C.O. (Board Certified Ocularist), the practice maintains collaborative relationships with ophthalmic reconstructive surgeons throughout Northern California and the Reno region. The company provides comprehensive patient care including insurance verification, benefit coordination, and authorization assistance. Services are delivered in a professional office setting with extended hours (Monday–Saturday, 8 AM–5 PM). The organization emphasizes high-quality care, maintenance, and long-term management of ocular prosthetic needs for patients requiring vision replacement and orbital rehabilitation.

MANI, INC. is a Japan-based manufacturer of precision surgical and dental instruments, established in 1956. The company specializes in fine wire processing and precision manufacturing for medical devices, serving global markets with a commitment to quality and clinical utility. MANI produces over 2,000 dental products, primarily endodontic instruments, rotary dental tools, and suturing devices. Their ophthalmic division manufactures surgical knives engineered for cataract and eye surgery procedures. The company emphasizes data-driven product verification and continuous improvement through skilled technician inspections and physician feedback integration. MANI maintains rigorous quality standards aligned with global regulatory requirements and serves surgeons and dental practitioners worldwide. Product development is shaped by clinical needs and functional requirements rather than marketing trends. The company operates with a philosophy focused on delivering the world's highest quality instruments.

OASIS Medical, Inc. is a medical device and drug manufacturer specializing in ophthalmic solutions for dry eye treatment and vision care. The company manufactures and distributes a comprehensive portfolio of dry eye relief products including artificial tear solutions (OASIS Tears®), punctal and intracanalicular plugs (SOFT PLUG® collagen and silicone variants, FORM FIT® hydrogel), and surgical ophthalmic instruments and accessories. Product lines include OTC dry eye solutions, punctal occlusion devices in multiple durations (90-day, 180-day extended duration), collagen bandages, viscoelastics, iris expansion devices, and surgical instruments branded as OASIS® and FEATHER®. The company serves ophthalmologists, optometrists, eye care practices, and patients through a B2B ordering platform (MyOASIS360) and direct patient access channels (MyOASIS). OASIS Medical maintains ISO standards compliance and operates manufacturing and distribution facilities in Glendora, California. The company emphasizes quality manufacturing, consultative customer service, and practice development support for eye care professionals. Distribution includes US and international markets, with dedicated customer service and account manager networks.

OcuJect, LLC is a clinical-stage medical device company specializing in advanced drug delivery technologies, with a primary focus on injectable drug delivery systems for biopharmaceuticals and soluble therapeutics. The company designs and engineers state-of-the-art ophthalmic injection devices and related consumables intended to enhance patient safety, improve physician productivity, and facilitate patient comfort during intravitreal and other ophthalmic injections. The firm's product portfolio includes the VITREJECT® ophthalmic safety needle (low dead space), the OCUSAFE® ophthalmic needle (low dead space), and the VITREJECT® ophthalmic syringe (silicone-free formulation). OcuJect's team comprises clinicians, engineers, and experienced medical device developers focused on bringing novel drug delivery solutions to market. The company's expertise spans the design, engineering, and commercialization of injectable medical devices for ophthalmic and broader biopharmaceutical applications. Products are marketed through a direct-to-customer e-commerce platform, indicating distribution to ophthalmology practices and healthcare facilities.

Cortigent, Inc. is a neuromodulation medical device company developing advanced brain implant systems for treating profound blindness and stroke-related paralysis. The company's core technology comprises a proprietary data processing unit that wirelessly controls microelectronic implants containing a unique 60-electrode array positioned on the brain's surface. These electrodes deliver targeted electrical stimulation to specific brain regions to either restore visual perception or enhance motor recovery. Orion® Visual Cortical Prosthesis System is Cortigent's lead product candidate, designed to provide artificial vision to patients with nearly all forms of profound blindness, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye trauma. The Orion system builds upon the legacy of Argus® Retinal Prosthesis System (Argus II), the world's first FDA-approved device for artificial vision in retinitis pigmentosa patients. Cortigent has discontinued Argus II to focus development on Orion, which targets a substantially larger patient population. A second development program addresses motor skill recovery in stroke patients. This neurostimulation system leverages the 60-channel electrode configuration to selectively target motor cortex neurons, intended to enhance hand and arm movement recovery in partially paralyzed stroke victims undergoing rehabilitation. As of January 2026, Cortigent presented promising six-year early feasibility study results for the Orion system at the North American Neuromodulation Society conference. The company is currently a subsidiary of Vivani Medical with active clinical studies recruiting prospective participants. All devices remain in clinical development or early-stage commercialization phases.

NeoLight, LLC manufactures specialized medical devices for neonatal intensive care, including brain monitoring, retinal imaging, phototherapy, and developmental support systems. The company's product portfolio addresses critical clinical needs in NICU environments: the nëo™ CFM with aEEG provides cerebral function monitoring to support decision-making in neurological assessment; the ICON™ retinal imaging system with patented Direct Illumination™ technology enables screening for retinopathy of prematurity and other ocular conditions; the Skylife™ Neonatal Phototherapy System delivers spectral power-optimized treatment for neonatal jaundice; and the P.A.L. (Pacifier-Activated Latch) device encourages non-nutritive sucking to promote oral feeding development in preterm and critically ill infants. NeoLight's devices are designed for use in tertiary and secondary neonatal care settings, emphasizing evidence-based clinical outcomes and user-centered design. The company positions itself as a neonatal innovation leader integrating advanced monitoring, diagnostic imaging, and therapeutic technologies to improve developmental outcomes and reduce NICU length of stay.

Avatar Medical USA Inc develops FDA-cleared and CE-marked 3D medical imaging visualization software that transforms DICOM medical images into interactive 3D patient avatars for clinical consultation, surgical planning, and medical education. The platform is hardware-agnostic and integrates with existing PACS systems without preprocessing requirements. It enables real-time 3D visualization suitable for multiple surgical specialties including neurosurgery, oncology, ENT, oral maxillofacial surgery, cardiovascular and vascular surgery, and urology. The software supports intraoperative guidance, multidisciplinary team collaboration, and patient engagement during pre- and post-operative consultations. Avatar Medical also offers Eonis Vision, a consultation-focused product, and Avatar Medical Academy for medical education. The platform supports extended reality (XR) interaction for immersive visualization. Clinical applications span from patient communication and informed consent to detailed surgical planning and training environments. The company serves major teaching hospitals and medical centers across North America and Europe, including Assistance Publique-Hôpitaux de Paris, Sorbonne University, and University of Miami.